It’s heart wrenching to hear stories like yours. To lend some insight, I have most of my patients on estrogen blockers as well. This is something that I find necessary even though we replace to the normal range only. We recommend against GHRP-6 and all growth hormone treatment, so I cant’ speak directly to that. His testosterone dose is higher than what I would start a patient at, but it’s not exorbitant. That, however, is only part of the picture. Proper dosing is dependent upon the observation of how a patient reacts to a dose over time. So, that dose could be entirely too high for him even though I would say it is on the spectrum of normal dosing in general.
Common (1% to 10%): Sinusitis, nasopharyngitis, upper respiratory tract infection, bronchitis
Uncommon (% to 1%): Cough, dyspnea, snoring, dysphonia
Rare (less than %): Pulmonary microembolism (POME) (cough, dyspnea, malaise, hyperhidrosis, chest pain, dizziness, paresthesia, or syncope) caused by oily solutions
Frequency not reported: Sleep apnea
Postmarketing reports: Chest pain, asthma, chronic obstructive pulmonary disease, hyperventilation, obstructive airway disorder, pharyngeal edema, pharyngolaryngeal pain, pulmonary embolism, respiratory distress, rhinitis, sleep apnea syndrome [ Ref ]